Drug information for ZYPREXA ZYDIS

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET, ORALLY DISINTEGRATING; ORAL 10MG Prescription AB  OLANZAPINE olanzapine LILLY 21086
2011-12-22 Other Important Information from FDA

2011-06-29 Medication Guide

2011-06-29 Label

2011-06-29 Label

2011-06-29 Medication Guide

2011-06-27 Letter

2011-06-27 Letter

2010-12-06 Letter

2010-12-04 Label

2010-06-03 Medication Guide

2010-06-03 Medication Guide

2010-06-03 Label

2010-06-03 Label

2010-06-03 Letter

2010-06-03 Letter

2010-02-01 Letter

2010-01-29 Label

2009-12-18 Other

2009-12-04 Medication Guide

2009-11-19 Letter

2009-09-17 Label

2009-03-20 Label

2008-08-19 Letter

2007-07-10 Label

2007-07-10 Label

2007-07-10 Letter

2007-07-10 Letter

2006-12-28 Letter

2006-12-04 Label

2006-09-18 Letter

2006-08-29 Label

2006-03-01 Letter

2006-02-28 Label

2005-09-15 Letter

2000-04-06 Label

2000-04-06 Letter

2000-04-06 Review
TABLET, ORALLY DISINTEGRATING; ORAL 15MG Prescription AB  OLANZAPINE olanzapine LILLY   "
TABLET, ORALLY DISINTEGRATING; ORAL 20MG Prescription AB  OLANZAPINE olanzapine LILLY   "
TABLET, ORALLY DISINTEGRATING; ORAL 5MG Prescription AB (Reference Drug) OLANZAPINE olanzapine LILLY   "

Drug Adverse Effects information for ZYPREXA ZYDIS

Role code Indications Reaction # Reports
PS ANXIETY AGITATION 1
PS ANXIETY OFF LABEL USE 1
PS MAJOR DEPRESSION ASPARTATE AMINOTRANSFERASE INCREASED 2
PS MAJOR DEPRESSION BLOOD CHOLESTEROL INCREASED 2
PS MAJOR DEPRESSION BLOOD TRIGLYCERIDES INCREASED 2
PS MAJOR DEPRESSION CEREBROVASCULAR ACCIDENT 2
PS MAJOR DEPRESSION DIABETES MELLITUS 2
PS MAJOR DEPRESSION DIABETIC NEUROPATHY 2
PS MAJOR DEPRESSION DRUG INEFFECTIVE 2
PS MAJOR DEPRESSION FIBROMYALGIA 2
PS MAJOR DEPRESSION GASTRECTOMY 2
PS MAJOR DEPRESSION HOSPITALISATION 2
PS MAJOR DEPRESSION HYPERTENSION 2
PS MAJOR DEPRESSION INCORRECT ROUTE OF DRUG ADMINISTRATION 2
PS MAJOR DEPRESSION LEFT VENTRICULAR HYPERTROPHY 2
PS MAJOR DEPRESSION MITRAL VALVE INCOMPETENCE 2
PS MAJOR DEPRESSION MYOCARDIAL INFARCTION 2
PS MAJOR DEPRESSION NEUROLEPTIC MALIGNANT SYNDROME 2
PS MAJOR DEPRESSION OESOPHAGECTOMY 2
PS MAJOR DEPRESSION OFF LABEL USE 4
PS MAJOR DEPRESSION OVERDOSE 2
PS MAJOR DEPRESSION SEROTONIN SYNDROME 2
PS MAJOR DEPRESSION TYPE 2 DIABETES MELLITUS 2
PS MAJOR DEPRESSION UPPER RESPIRATORY TRACT INFECTION 2
PS MAJOR DEPRESSION WEIGHT INCREASED 2
PS SCHIZOPHRENIA BLOOD CHOLESTEROL INCREASED 2
PS SCHIZOPHRENIA HAEMATEMESIS 2
PS SCHIZOPHRENIA HEPATITIS B 2
PS SCHIZOPHRENIA HYPERGLYCAEMIA 2
PS SCHIZOPHRENIA WEIGHT INCREASED 2
PS SCHIZOPHRENIA, PARANOID TYPE CLOSTRIDIUM TEST POSITIVE 2
PS SCHIZOPHRENIA, PARANOID TYPE DIABETES MELLITUS 2
PS SCHIZOPHRENIA, PARANOID TYPE PANCREATITIS HAEMORRHAGIC 2
PS SCHIZOPHRENIA, PARANOID TYPE PSEUDOCYST 2
PS VASCULAR DEMENTIA AGGRESSION 1
PS VASCULAR DEMENTIA AGITATION 1
PS VASCULAR DEMENTIA OFF LABEL USE 1
PS VASCULAR DEMENTIA RESTLESSNESS 1
SS AGITATION DRUG EFFECT DELAYED 2
SS AGITATION HYPONATRAEMIA 2
SS AGITATION OFF LABEL USE 2
SS AGITATION PNEUMONIA 2
SS DEPRESSION GASTRIC DISORDER 1
SS DEPRESSION OFF LABEL USE 1
SS DEPRESSION PSYCHOTIC DISORDER 1
SS DEPRESSION WRONG TECHNIQUE IN DRUG USAGE PROCESS 1
SS INSOMNIA GASTRIC DISORDER 1
SS INSOMNIA OFF LABEL USE 1
SS INSOMNIA PSYCHOTIC DISORDER 1
SS INSOMNIA WRONG TECHNIQUE IN DRUG USAGE PROCESS 1
SS MAJOR DEPRESSION ASPARTATE AMINOTRANSFERASE INCREASED 6
SS MAJOR DEPRESSION BLOOD CHOLESTEROL INCREASED 6
SS MAJOR DEPRESSION BLOOD TRIGLYCERIDES INCREASED 6
SS MAJOR DEPRESSION CEREBROVASCULAR ACCIDENT 6
SS MAJOR DEPRESSION DIABETES MELLITUS 6
SS MAJOR DEPRESSION DIABETIC NEUROPATHY 6
SS MAJOR DEPRESSION HYPERTENSION 6
SS MAJOR DEPRESSION LEFT VENTRICULAR HYPERTROPHY 6
SS MAJOR DEPRESSION MITRAL VALVE INCOMPETENCE 6
SS MAJOR DEPRESSION MYOCARDIAL INFARCTION 6
SS MAJOR DEPRESSION NEUROLEPTIC MALIGNANT SYNDROME 6
SS MAJOR DEPRESSION OFF LABEL USE 6
SS MAJOR DEPRESSION OVERDOSE 6
SS MAJOR DEPRESSION SEROTONIN SYNDROME 6
SS MAJOR DEPRESSION TYPE 2 DIABETES MELLITUS 6
SS MAJOR DEPRESSION UPPER RESPIRATORY TRACT INFECTION 6
SS MAJOR DEPRESSION WEIGHT INCREASED 6
SS PSYCHOTIC DISORDER CATATONIA 3
SS PSYCHOTIC DISORDER GASTRIC DISORDER 1
SS PSYCHOTIC DISORDER NEUROLEPTIC MALIGNANT SYNDROME 3
SS PSYCHOTIC DISORDER OFF LABEL USE 1
SS PSYCHOTIC DISORDER PSYCHOTIC DISORDER 1
SS PSYCHOTIC DISORDER WRONG TECHNIQUE IN DRUG USAGE PROCESS 1
SS SCHIZOPHRENIA BLOOD CHOLESTEROL INCREASED 4
SS SCHIZOPHRENIA BLOOD SODIUM DECREASED 4
SS SCHIZOPHRENIA CEREBROVASCULAR ACCIDENT 4
SS SCHIZOPHRENIA DIABETES MELLITUS 4
SS SCHIZOPHRENIA FALL 4
SS SCHIZOPHRENIA HAEMATEMESIS 4
SS SCHIZOPHRENIA HEPATITIS B 4
SS SCHIZOPHRENIA HYPERGLYCAEMIA 4
SS SCHIZOPHRENIA HYPERTENSION 4
SS SCHIZOPHRENIA LOSS OF CONSCIOUSNESS 4
SS SCHIZOPHRENIA PLEURAL EFFUSION 4
SS SCHIZOPHRENIA PNEUMONIA 4
SS SCHIZOPHRENIA RESPIRATORY DISTRESS 4
SS SCHIZOPHRENIA SYNCOPE 4
SS SCHIZOPHRENIA WEIGHT INCREASED 4
SS SCHIZOPHRENIA WHITE BLOOD CELL COUNT INCREASED 4
SS SCHIZOPHRENIA, PARANOID TYPE ABDOMINAL PAIN UPPER 6
SS SCHIZOPHRENIA, PARANOID TYPE ALANINE AMINOTRANSFERASE INCREASED 6
SS SCHIZOPHRENIA, PARANOID TYPE BLINDNESS 6
SS SCHIZOPHRENIA, PARANOID TYPE BONE PAIN 6
SS SCHIZOPHRENIA, PARANOID TYPE BRUXISM 6
SS SCHIZOPHRENIA, PARANOID TYPE CEREBROVASCULAR ACCIDENT 6
SS SCHIZOPHRENIA, PARANOID TYPE CHEST PAIN 6
SS SCHIZOPHRENIA, PARANOID TYPE CLOSTRIDIUM TEST POSITIVE 4
SS SCHIZOPHRENIA, PARANOID TYPE CONVULSION 6
SS SCHIZOPHRENIA, PARANOID TYPE DIABETES MELLITUS 10
SS SCHIZOPHRENIA, PARANOID TYPE DRY MOUTH 6
SS SCHIZOPHRENIA, PARANOID TYPE DYSKINESIA 6
SS SCHIZOPHRENIA, PARANOID TYPE DYSPNOEA 6
SS SCHIZOPHRENIA, PARANOID TYPE HAEMOGLOBIN DECREASED 6
SS SCHIZOPHRENIA, PARANOID TYPE HEADACHE 6
SS SCHIZOPHRENIA, PARANOID TYPE HYPERGLYCAEMIA 6
SS SCHIZOPHRENIA, PARANOID TYPE HYPOAESTHESIA 6
SS SCHIZOPHRENIA, PARANOID TYPE HYPOKINESIA 6
SS SCHIZOPHRENIA, PARANOID TYPE INSOMNIA 6
SS SCHIZOPHRENIA, PARANOID TYPE NAUSEA 6
SS SCHIZOPHRENIA, PARANOID TYPE OVERDOSE 6
SS SCHIZOPHRENIA, PARANOID TYPE PAIN 6
SS SCHIZOPHRENIA, PARANOID TYPE PANCREATITIS HAEMORRHAGIC 4
SS SCHIZOPHRENIA, PARANOID TYPE PSEUDOCYST 4
SS SCHIZOPHRENIA, PARANOID TYPE RED BLOOD CELL COUNT DECREASED 6
SS SCHIZOPHRENIA, PARANOID TYPE TOOTH INJURY 6
SS SCHIZOPHRENIA, PARANOID TYPE TREMOR 6
SS SCHIZOPHRENIA, PARANOID TYPE VISION BLURRED 6
SS SCHIZOPHRENIA, PARANOID TYPE VOMITING 6
SS SCHIZOPHRENIA, PARANOID TYPE WEIGHT INCREASED 6
SS SCHIZOPHRENIA, PARANOID TYPE WHITE BLOOD CELL COUNT INCREASED 6
SS VASCULAR DEMENTIA AGGRESSION 1
SS VASCULAR DEMENTIA AGITATION 1
SS VASCULAR DEMENTIA OFF LABEL USE 1
SS VASCULAR DEMENTIA RESTLESSNESS 1
C ANTICOAGULANT THERAPY ANAPHYLACTIC SHOCK 1
C ANTICOAGULANT THERAPY ATRIAL FIBRILLATION 1
C ANTICOAGULANT THERAPY DRUG INTERACTION 1
C ANTICOAGULANT THERAPY GASTROINTESTINAL HAEMORRHAGE 1
C ANTICOAGULANT THERAPY HAEMOPTYSIS 1
C ANTICOAGULANT THERAPY RECTAL HAEMORRHAGE 1
C BLOOD PRESSURE ANAPHYLACTIC SHOCK 1
C BLOOD PRESSURE ATRIAL FIBRILLATION 1
C BLOOD PRESSURE DRUG INTERACTION 1
C BLOOD PRESSURE GASTROINTESTINAL HAEMORRHAGE 1
C BLOOD PRESSURE HAEMOPTYSIS 1
C BLOOD PRESSURE RECTAL HAEMORRHAGE 1
C DEEP VEIN THROMBOSIS ANAPHYLACTIC SHOCK 1
C DEEP VEIN THROMBOSIS ATRIAL FIBRILLATION 1
C DEEP VEIN THROMBOSIS DRUG INTERACTION 1
C DEEP VEIN THROMBOSIS GASTROINTESTINAL HAEMORRHAGE 1
C DEEP VEIN THROMBOSIS HAEMOPTYSIS 1
C DEEP VEIN THROMBOSIS RECTAL HAEMORRHAGE 1
C DEMENTIA ANAPHYLACTIC SHOCK 1
C DEMENTIA ATRIAL FIBRILLATION 1
C DEMENTIA DRUG INTERACTION 1
C DEMENTIA GASTROINTESTINAL HAEMORRHAGE 1
C DEMENTIA HAEMOPTYSIS 1
C DEMENTIA RECTAL HAEMORRHAGE 1
C INSOMNIA ANAPHYLACTIC SHOCK 1
C INSOMNIA ATRIAL FIBRILLATION 1
C INSOMNIA DRUG INTERACTION 1
C INSOMNIA GASTROINTESTINAL HAEMORRHAGE 1
C INSOMNIA HAEMOPTYSIS 1
C INSOMNIA RECTAL HAEMORRHAGE 1
C LUNG INFILTRATION ANAPHYLACTIC SHOCK 1
C LUNG INFILTRATION ATRIAL FIBRILLATION 1
C LUNG INFILTRATION DRUG INTERACTION 1
C LUNG INFILTRATION GASTROINTESTINAL HAEMORRHAGE 1
C LUNG INFILTRATION HAEMOPTYSIS 1
C LUNG INFILTRATION RECTAL HAEMORRHAGE 1
Ads by Google